{"id":179440,"date":"2026-07-31T15:03:20","date_gmt":"2026-07-31T09:33:20","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=179440"},"modified":"2026-07-31T15:03:20","modified_gmt":"2026-07-31T09:33:20","slug":"concord-biotech-ltd-share-price-rise-today-2","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/concord-biotech-ltd-share-price-rise-today-2\/","title":{"rendered":"Concord Biotech Ltd. (CONCORDBIO): Concord Biotech Share Price Rises 6.05% Amid Market Activity"},"content":{"rendered":"<style id=\"univest-disable-toc\">#ez-toc-container,.ez-toc-container,.lwptoc,.toc_container,.wp-block-rank-math-toc-block{display:none!important}<\/style>\n<p style=\"margin-top:0!important;margin-bottom:0!important;\">Concord Biotech Share Price rises 6.05% to Rs 1,413.85, with a market cap of Rs 13,915 crore.<\/p>\n<p style=\"margin-top:0!important;\">Concord Biotech Share Price has experienced a notable rise today, increasing by 6.05% to reach Rs 1,413.85. This price movement has elevated the company&#8217;s market capitalisation to Rs 13,915 crore, positioning it as a significant player in the mid cap category. The stock opened at Rs 1,321.35 and reached a high of Rs 1,420.85, reflecting strong investor interest. The day&#8217;s trading volume was substantial, with a total of 472,555 shares exchanged across BSE and NSE.<\/p>\n<p><  While the data confirms the price event, it does not establish a specific catalyst for this movement. Investors and analysts will be keen to explore the technical and fundamental aspects that may have contributed to this performance.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Concord_Biotech_Ltd_CONCORDBIO_Share_Price_Today_Price_Action_Analysis\"><\/span><strong>Concord Biotech Ltd. (CONCORDBIO) Share Price Today: Price Action Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Current Price<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1,413.85<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Previous Close<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1,333.2<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Today&#39;s Change<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">+Rs 80.65 (+6.05%)<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Day Open<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1,321.35<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Day High<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1,420.85<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Day Low<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1,321.35<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Current Volume (BSE)<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">28,856<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>BSE Traded Volume<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">28,856<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>NSE Traded Volume<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">4,43,699<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Combined NSE + BSE Volume<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">4,72,555<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Turnover<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 4.08 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 13,915 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Cap Category<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Mid Cap<\/td>\n<\/tr>\n<\/table>\n<p>Concord Biotech Ltd. (CONCORDBIO) traded at Rs 1,413.85. versus the previous close of Rs 1,333.2, a rise of 6.05%. The stock opened at Rs 1,321.35, reached Rs 1,420.85, touched Rs 1,321.35. Reported volume was 28,856.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Concord_Biotech_Ltd_CONCORDBIO_Fundamental_Analysis\"><\/span><strong>Concord Biotech Ltd. (CONCORDBIO) Fundamental Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 13,915 crore<\/td>\n<\/tr>\n<\/table>\n<p>The healthcare sector, with a benchmark P\/E median of 25.77 and an average of 94.79, sets a context for evaluating Concord Biotech&#8217;s performance. The sector&#8217;s P\/B median is 1.93, with an average of 2.53, offering a benchmark for comparison. Concord Biotech&#8217;s financial metrics, such as ROE and ROCE, are essential for assessing its profitability and efficiency, although specific figures are not available in the data.<\/p>\n<p>Investors will be interested in Concord Biotech&#8217;s growth prospects and financial health, especially in comparison to its peers. The company&#8217;s ability to generate returns and manage its capital effectively will be key factors in sustaining investor interest.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Sector_and_Industry_Context\"><\/span><strong>Sector and Industry Context<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Sector<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Healthcare<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Scope<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">same sector<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">25.77x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">94.79x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark P\/E Range<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">3.3x to 3,417.8x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/B<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">1.93x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">10.74%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">13.24%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 13,915 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median Market Cap<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 140.91 crore<\/td>\n<\/tr>\n<\/table>\n<p>Concord Biotech Ltd. (CONCORDBIO) is classified under sector: Healthcare.<\/p>\n<p>Track today&#8217;s top gainers through the <a href=\"https:\/\/univest.in\/screeners\/top-gainers\">Univest top gainers screener<\/a>. The peer table below provides the company-level comparison.<\/p>\n<p>The healthcare sector, encompassing 198 companies, provides a broad benchmark for evaluating Concord Biotech&#8217;s performance. With a sector P\/E median of 25.77 and an average of 94.79, the industry presents a diverse range of valuations. Concord Biotech&#8217;s market capitalisation of Rs 13,915 crore places it above the sector median of Rs 140.91 crore, highlighting its significant market presence.<\/p>\n<p>The sector&#8217;s P\/B median of 1.93 and average of 2.53 offer a context for assessing Concord Biotech&#8217;s valuation. The company&#8217;s ROE and ROCE metrics, although not specified, are critical for understanding its profitability relative to the sector&#8217;s median ROE of 10.74% and ROCE of 13.24%. These benchmarks provide a framework for evaluating Concord Biotech&#8217;s financial performance and market positioning.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Peer_Comparison\"><\/span><strong>Peer Comparison<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Company<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Symbol<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Market Cap (Cr)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/E<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/B<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROE (%)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROCE (%)<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/dcal\/dishman-carbogen-amcis-ltd-share-price-today\"><strong>Dishman Carbogen Amcis Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">DCAL<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2,950.66<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">0<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">0.75<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">-2.89<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">-0.26<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/hikal\/hikal-ltd-share-price-today\"><strong>Hikal Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">HIKAL<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2,726.18<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">0<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2.23<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">15.22<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">16.15<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/kpl\/kwality-pharmaceuticals-ltd-share-price-today\"><strong>Kwality Pharmaceuticals Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">KPL<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2,700.98<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">39.17<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">7.93<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">28.21<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">26.35<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/panaceabio\/panacea-biotec-ltd-share-price-today\"><strong>Panacea Biotec Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">PANACEABIO<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2,598.26<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">0<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">8.89<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">0<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">5.36<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/beta\/beta-drugs-ltd-share-price-today\"><strong>Beta Drugs Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">BETA<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2,475.7<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">58.88<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">9.32<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">18.65<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">22.17<\/td>\n<\/tr>\n<\/table>\n<p>Concord Biotech Ltd. (CONCORDBIO) has a market capitalisation of Rs 13,915 crore. Among the 5 peers shown, 0 have a larger market capitalisation.<\/p>\n<p>In the healthcare sector, Concord Biotech competes with several peers, including Dishman Carbogen Amcis Ltd., Hikal Ltd., and Kwality Pharmaceuticals Ltd. These companies offer a range of market capitalisations and financial metrics, providing a comparative backdrop for Concord Biotech&#8217;s performance.<\/p>\n<p>Dishman Carbogen Amcis Ltd. has a market cap of Rs 2,950.66 crore, with a P\/B ratio of 0.75 and negative ROE and ROCE. Hikal Ltd. presents a market cap of Rs 2,726.18 crore, with a P\/B of 2.23, ROE of 15.22%, and ROCE of 16.15%. Kwality Pharmaceuticals Ltd. stands out with a P\/E of 39.17, P\/B of 7.93, and ROE of 28.21%, highlighting its strong financial performance.<\/p>\n<p>Concord Biotech&#8217;s market cap of Rs 13,915 crore positions it well above these peers, indicating its substantial market presence. The comparison of financial metrics, such as P\/E, P\/B, ROE, and ROCE, provides insights into Concord Biotech&#8217;s relative strengths and areas for improvement.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Why_Investors_Are_Watching_Concord_Biotech\"><\/span><strong>Why Investors Are Watching Concord Biotech<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Concord Biotech&#8217;s recent price rise has captured the attention of investors and analysts. The company&#8217;s strong market presence and performance in the healthcare sector make it a stock to watch.<\/p>\n<ul>\n<li><strong>Price Action:<\/strong> A 6.05% rise today, surpassing the mid cap threshold.<\/li>\n<li><strong>Technical Position:<\/strong> Strong upward momentum observed.<\/li>\n<li><strong>Fundamental Context:<\/strong> Significant market cap in the healthcare sector.<\/li>\n<li><strong>Sector Positioning:<\/strong> Above median market cap, indicating strong presence.<\/li>\n<\/ul>\n<p>Investors should monitor Concord Biotech&#8217;s financial performance, market trends, and sector developments to understand its future trajectory. The company&#8217;s ability to sustain growth and profitability will be key factors in maintaining investor interest.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"About_Concord_Biotech\"><\/span><strong>About Concord Biotech<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Concord Biotech Ltd. operates within the healthcare sector, focusing on the development and manufacturing of biopharmaceutical products. The company is involved in various segments, including pharmaceuticals and drugs, contributing to its substantial market presence. Concord Biotech&#8217;s operations are aligned with industry standards, ensuring high-quality product offerings.<\/p>\n<p>The company&#8217;s revenue mix and product portfolio are designed to cater to diverse market needs, positioning it as a competitive player in the healthcare industry. Concord Biotech&#8217;s commitment to innovation and quality has enabled it to maintain a strong foothold in the market, attracting interest from investors and stakeholders alike.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Track_Concord_Biotech_Share_Price_on_Univest\"><\/span><strong>Track Concord Biotech Share Price on Univest<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Use <a href=\"https:\/\/univest.in\/stocks\/concordbio\/concord-biotech-ltd-share-price-today\">Concord Biotech Ltd. (CONCORDBIO) live share-price page<\/a>, <a href=\"https:\/\/univest.in\/screeners\/top-gainers\">Univest top gainers screener<\/a>, <a href=\"https:\/\/univest.in\/blogs\">Univest market blogs<\/a> to review live stock data, top gainers lists and related market analysis.<\/p>\n<p>Investors can track Concord Biotech Share Price on Univest for real-time updates and insights. Univest provides comprehensive data, including live share prices, technical indicators, fundamental ratios, and shareholding patterns. Users can also access 52-week levels and market insights to make informed investment decisions.<\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/div>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions\"><\/span><strong>Frequently Asked Questions<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"What_is_Concord_Biotechs_current_share_price\"><\/span><strong>What is Concord Biotech&#39;s current share price?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Concord Biotech&#39;s current share price is Rs 1,413.85, reflecting a 6.05% increase from the previous close of Rs 1,333.20. The stock moved 6.05% during the session. The intraday range extended from Rs 1,321.35 to Rs 1,420.85.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_much_did_Concord_Biotechs_share_price_rise_today\"><\/span><strong>How much did Concord Biotech&#39;s share price rise today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Concord Biotech&#39;s share price rose by 6.05% today, marking a significant gain in the mid cap category. The stock moved 6.05% during the session. The intraday range extended from Rs 1,321.35 to Rs 1,420.85.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_does_Concord_Biotechs_market_cap_compare_to_its_peers\"><\/span><strong>How does Concord Biotech&#39;s market cap compare to its peers?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Concord Biotech&#39;s market cap of Rs 13,915 crore is substantially higher than its peers, indicating a strong market presence. The company operates in the Healthcare sector. Comparable listed companies include Dishman Carbogen Amcis Ltd., Hikal Ltd., Kwality Pharmaceuticals Ltd.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_sector_PE_median_for_healthcare\"><\/span><strong>What is the sector P\/E median for healthcare?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The sector P\/E median for healthcare is 25.77, providing a benchmark for evaluating Concord Biotech&#39;s valuation. The relevant peer median P\/E is 25.77x. The peer average P\/E is 94.79x. The stock belongs to the Healthcare sector.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Who_are_Concord_Biotechs_main_competitors\"><\/span><strong>Who are Concord Biotech&#39;s main competitors?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Concord Biotech&#39;s main competitors include Dishman Carbogen Amcis Ltd., Hikal Ltd., and Kwality Pharmaceuticals Ltd., among others. Comparable listed companies include Dishman Carbogen Amcis Ltd., Hikal Ltd., Kwality Pharmaceuticals Ltd.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Concord Biotech Ltd. Share Price rises to Rs Rs 1,413.85. marking a 6.05% rise today. clearing the 5% threshold for Mid Cap stocks. Market cap stands at Rs<\/p>\n","protected":false},"author":29,"featured_media":179439,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[],"class_list":["post-179440","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["179439"],"rank_math_title":["Concord Biotech Share Price Rises 6.05% Amid Market Activity"],"rank_math_description":["Concord Biotech Share Price rises 6.05% today, marking a significant gain in the mid cap category. Explore the price action, technicals, and sector"],"rank_math_focus_keyword":["Concord Biotech Share Price"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/07\/Concord_Biotech_Ltd_CONCORDBIO_Concord_Biotech_Share_Price_Rises_605_Amid_Market_Activity_bullish.png","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/179440","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/29"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=179440"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/179440\/revisions"}],"predecessor-version":[{"id":179441,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/179440\/revisions\/179441"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/179439"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=179440"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=179440"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=179440"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}